Literature DB >> 16290072

Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis.

Yoshinobu Okuda1, Brian R Apatoff, David N Posnett.   

Abstract

Apoptotic elimination of pathogenic T cells is considered to be one of regulatory mechanisms in multiple sclerosis (MS). To explore the potential relationship between Fas-mediated apoptosis and the disease course of MS, we examined apoptosis, defined by annexin V (AV) binding, and Fas (CD95) expression in CD4+ and in CD8+ T cells in MS patients by using five-color flow cytometry. The percentage of AV+CD4+CD3+ cells and CD95+AV+CD4+CD3+ cells in peripheral blood and cerebrospinal fluid (CSF) were significantly decreased in active MS patients compared with inactive MS patients. A significantly lower proportion of CD95+AV+CD8+CD3+ cells in CSF was observed in active MS patients compared with inactive MS patients, but not in peripheral blood. These results indicate that the resistance of T cells to Fas-mediated apoptosis is involved in exacerbation of MS and/or that Fas-mediated apoptosis of T cells is associated with remission of MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16290072     DOI: 10.1016/j.jneuroim.2005.09.020

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; A F Ferreira; E P L Gasparotto; S Kashima; D T Covas; C T Guerreiro; D G Brum; A A Barreira; J C Voltarelli; B P Simões; M C Oliveira; F A de Castro; K C R Malmegrim
Journal:  Clin Exp Immunol       Date:  2016-12-23       Impact factor: 4.330

2.  RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.

Authors:  Adam M Kruszewski; Gautam Rao; Alexandru Tatomir; Daniel Hewes; Cosmin A Tegla; Cornelia D Cudrici; Vingh Nguyen; Walter Royal; Christopher T Bever; Violeta Rus; Horea Rus
Journal:  Exp Mol Pathol       Date:  2015-09-25       Impact factor: 3.362

3.  Fewer LAG-3+ T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes.

Authors:  Britta E Jones; Megan D Maerz; Henry T Bahnson; Ashwin Somasundaram; Lucas H McCarthy; Cate Speake; Jane H Buckner
Journal:  J Immunol       Date:  2022-01-12       Impact factor: 5.422

4.  A Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation.

Authors:  Soraya Maria Menezes; Fabio E Leal; Tim Dierckx; Ricardo Khouri; Daniele Decanine; Gilvaneia Silva-Santos; Saul V Schnitman; Ramon Kruschewsky; Giovanni López; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Douglas F Nixon; Jurgen Vercauteren; David Brassat; Roland Liblau; Anne Mieke Vandamme; Bernardo Galvão-Castro; Johan Van Weyenbergh
Journal:  Front Immunol       Date:  2017-02-14       Impact factor: 7.561

5.  The IL-27/IL-27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patients.

Authors:  Marie-Laure Clénet; Cyril Laurent; Florent Lemaitre; Negar Farzam-Kia; Olivier Tastet; Odile Devergne; Boaz Lahav; Marc Girard; Pierre Duquette; Alexandre Prat; Catherine Larochelle; Nathalie Arbour
Journal:  Clin Transl Immunology       Date:  2021-03-05

6.  MK2 and Fas receptor contribute to the severity of CNS demyelination.

Authors:  Silvia M Tietz; Regina Hofmann; Tobias Thomas; Björn Tackenberg; Matthias Gaestel; Martin Berghoff
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.